Merge revenues sag in second quarter

Article

Merge revenues sag in second quarterMerge Technologies of Milwaukee was hurt by disappointing end-user sales during its second quarter. The company's revenues dropped 9.5% for the campaign (end-June).Revenues were $1.9 million, compared with

Merge revenues sag in second quarter

Merge Technologies of Milwaukee was hurt by disappointing end-user sales during its second quarter. The company's revenues dropped 9.5% for the campaign (end-June).

Revenues were $1.9 million, compared with $2.1 million in 1997. The company posted a net loss of $683,000, compared with net income of $247,000 in the same period last year.

Merge executives believe the decrease in end-user sales is a temporary dip, and the company is deploying additional resources to reach more of its target audience in the U.S. and Europe. The company's sales through OEMs and value-added resellers performed as expected.

In other Merge news, the company began shipments of its MergeARK low-cost archiving offering last month. MergeARK supports online storage via redundant arrays of inexpensive disks (RAID) as well as CD-R media.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.